Literature DB >> 31897533

Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report.

Dario Cattaneo1,2, Tiziana Formenti3, Bronzino Isabella4, Carlo Filice5, Marta Fusi2, Cristina Gervasoni6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31897533     DOI： 10.1007/s00228-019-02825-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Ursodeoxycholic acid causing exacerbation of dermatitis herpetiformis.

Authors:  E Stroubou; G Dawn; A Forsyth
Journal:  J Am Acad Dermatol       Date:  2001-08       Impact factor: 11.527

Review 2.  Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

Authors:  K N Lazaridis; G J Gores; K D Lindor
Journal:  J Hepatol       Date:  2001-07       Impact factor: 25.083

3.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.

Authors:  J L Staudinger; B Goodwin; S A Jones; D Hawkins-Brown; K I MacKenzie; A LaTour; Y Liu; C D Klaassen; K K Brown; J Reinhard; T M Willson; B H Koller; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Management of Polypharmacy and Drug-Drug Interactions in HIV Patients: A 2-year Experience of a Multidisciplinary Outpatient Clinic

Authors:  Cristina Gervasoni; Tiziana Formenti; Dario Cattaneo
Journal:  AIDS Rev       Date:  2019       Impact factor: 2.500

5.  Effect of bile acids on absorption of nitrendipine in healthy subjects.

Authors:  M Sasaki; A Maeda; K Sakamoto; A Fujimura
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

6.  Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.

Authors:  E G Schuetz; S Strom; K Yasuda; V Lecureur; M Assem; C Brimer; J Lamba; R B Kim; V Ramachandran; B J Komoroski; R Venkataramanan; H Cai; C J Sinal; F J Gonzalez; J D Schuetz
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

7.  Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.

Authors:  Laurent Becquemont; Hartmut Glaeser; Siegfried Drescher; Monika Hitzl; Nicolas Simon; Thomas E Murdter; Georg Heinkele; Ute Hofmann; Christian Schaefer; Oliver Burk; Céline Verstuyft; Michel Eichelbaum; Martin F Fromm
Journal:  Clin Pharmacol Ther       Date:  2006-04-11       Impact factor: 6.875

8.  Effects of ursodeoxycholic acid on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam in healthy volunteers.

Authors:  Dongmei Yan; Yingbao Yang; Sinya Uchida; Shingen Misaka; Jinghui Luo; Kazuhiko Takeuchi; Naoki Inui; Shizuo Yamada; Kyoichi Ohashi; Hiroshi Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

Review 9.  Systematic review: ursodeoxycholic acid--adverse effects and drug interactions.

Authors:  W Hempfling; K Dilger; U Beuers
Journal:  Aliment Pharmacol Ther       Date:  2003-11-15       Impact factor: 8.171

Review 10.  Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor.

Authors:  Lucy Garvey; Alan Winston
Journal:  Expert Opin Investig Drugs       Date:  2009-07       Impact factor: 6.206
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.